Drug comparisons
Canagliflozin vs Saxagliptin
Canagliflozin (Invokana) vs Saxagliptin (Onglyza): SGLT2 vs DPP-4 inhibitors for T2D. Differences in mechanism, efficacy, safety, and CV protection.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when choosing between an SGLT2 inhibitor and a DPP-4 inhibitor as add-on oral therapy for type 2 diabetes.
Bottom line
Neither is better overall because they target type 2 diabetes via distinct mechanisms with unique benefits and risks.
All medication comparisons